A new study led by investigators at National Jewish Health and published in Annals of Allergy, Asthma & Immunology shows that ...

Presentations among children with multiple food allergies vary by allergen combination, indicating distinct phenotypes, according to a poster presented at the American Academy of Allergy, Asthma & ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the ...

FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly announced on Friday safety ...

The US Food and Drug Administration (FDA) today announced it has expanded the approval of tralokinumab-ldrm (Adbry) for treating moderate to severe atopic dermatitis (AD) in children 12-17 years old, ...

Turn Therapeutics (NASDAQ:TTRX) executives outlined the company’s focus on inflammatory skin disease and provided updates on ...

A clinical review breaks down the latest best practices for managing severe atopic dermatitis (AD) in pregnancy. The review, which appears in Clinical Medicine, was developed by a team of British ...

"I have severe eczema. Many other creams help but this moisturiser seems to be able to calm and heal the 'break out' significantly faster." ...

Nara Smith has been transparent about her struggles with her eczema over the years Nara Smith/Instagram; Daniele Venturelli/Getty Nara Smith has been transparent about her struggles with her eczema ...